Hirotada Nagai
Directeur/Membre du Conseil chez STEMRIM
Provenance du réseau au premier degré de Hirotada Nagai
Entité | Type d'entité | Industrie | |
---|---|---|---|
8
| Public Company | Miscellaneous Commercial Services | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Hirotada Nagai via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
MEDICINOVA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CARNA BIOSCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
ECS Co., Ltd.
ECS Co., Ltd. Miscellaneous Commercial ServicesCommercial Services ECS Co., Ltd. is a consultant firm. The company offers general consulting services such as management and administration consulting. ECS Co., Ltd. was established in 1991 and is based in Tokyo, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
ONCOTHERAPY SCIENCE, INC. | Biotechnology | Chairman | |
MEDINET CO., LTD. | Biotechnology | Director/Board Member | |
Daiwa Securities SB Capital Markets Co. Ltd.
Daiwa Securities SB Capital Markets Co. Ltd. Investment ManagersFinance Part of Daiwa Securities Group, Inc., Daiwa Securities SB Capital Markets Co. Ltd. provides asset management services. | Investment Managers | Corporate Officer/Principal | |
University of Tokyo | College/University | Undergraduate Degree Graduate Degree | |
Japan Asia Investment Co. Ltd. (Private Equity)
Japan Asia Investment Co. Ltd. (Private Equity) Investment ManagersFinance Japan Asia Investment Co. Ltd. (JAIC) is a private equity and venture capital arm of Japan Asia Investment Co., Ltd. founded in 1981. The firm is headquartered in Tokyo, Japan. | Investment Managers | Corporate Officer/Principal | |
FUTURE VENTURE CAPITAL CO., LTD. | Investment Managers | Director/Board Member | |
JAIC America, Inc.
JAIC America, Inc. Investment ManagersFinance JAIC America, Inc. (JAIC America) is a venture capital subsidiary of Japan Asia Investment Co., Ltd. founded in 1999. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
A-CUBE, Inc.
A-CUBE, Inc. BiotechnologyHealth Technology A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA. | Biotechnology | Director/Board Member | |
M3i, Inc. | Investment Managers | Chief Executive Officer | |
POC Clinical Research, Inc. | Director/Board Member | ||
PorMedTec Co., Ltd.
PorMedTec Co., Ltd. BiotechnologyHealth Technology PorMedTec Co., Ltd. is a Japanese company that specializes in the development of medical pigs for organ transplantation and regenerative medicine. The company was founded in 2017 by Genjiro Miwa and is based in Kawasaki, Japan. PorMedTec aims to provide solutions to the overwhelming lack of organ donors by using pigs for organ transplantation and regenerative organs. The company develops and uses high-value pigs developed for medical purposes and supplies products inexpensively and stably. PorMedTec also offers technical services such as custom-made gene modification pigs and cloning pigs as models for developing drugs and treatments. | Biotechnology | Director/Board Member | |
Sumitomo Capital Securities Co., Ltd.
Sumitomo Capital Securities Co., Ltd. Investment Banks/BrokersFinance Part of Sumitomo Corp., Sumitomo Capital Securities Co., Ltd. provides financial security services. The company is based in Tokyo, Japan. | Investment Banks/Brokers | Corporate Officer/Principal |
Statistiques
Internationale
Japon | 14 |
Etats-Unis | 4 |
Sectorielle
Finance | 8 |
Health Technology | 7 |
Commercial Services | 2 |
Consumer Services | 2 |
Opérationnelle
Director/Board Member | 14 |
Corporate Officer/Principal | 8 |
President | 6 |
Chief Executive Officer | 3 |
Chief Tech/Sci/R&D Officer | 3 |
Relations les plus connectées
- Bourse
- Insiders
- Hirotada Nagai
- Connexions Sociétés